Department of Otorhinolaryngology Head- and Neck Surgery, Aarhus University Hospital (AUH), Aarhus, Denmark.
Department of Endocrinology, Odense University Hospital (OUH), Odense, Denmark.
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4979-4985. doi: 10.1007/s00405-021-06733-5. Epub 2021 Mar 13.
The risk of malignancy (ROM) in FDG-avid thyroid incidentalomas varies between studies, which may be contributed by discordance between the anatomical localization depicted on FDG-PET/CT and by histopathological examination. The purpose was to ensure anatomical congruity between the index tumour identified by FDG-PET/CT and the histopathological examination, in order to assess the risk of malignancy (ROM) in PET-positive and PET-negative thyroid nodules. Further, preoperative characteristics indicative of thyroid malignancy were identified.
Thirty-two patients referred to thyroid surgery were prospectively included. FDG-PET/CT, fine-needle aspiration biopsy and thyroid ultrasonography examination were performed in all participants. The exact anatomical localization of the index nodule was established by histopathological examination to ensure concordance with the FDG-PET/CT finding.
Forty thyroid nodules were included. Malignancy was identified in 10 of 28 PET-positive nodules and in 1 of 12 PET-negative nodules, resulting in a ROM of 36% and 8%, respectively. A Hurtle cell neoplasm was found in 50% of patients with a benign nodule and a PET-positive scan. One PET-negative nodule represented a papillary microcarcinoma. In PET-positive nodules, hypoechogenicity, irregular margins, and pathological lymph nodes on thyroid ultrasonography were characteristics associated with malignancy.
In this study-ensuring anatomical congruity between PET-findings and the histopathological examination-the risk of malignancy in PET-positive thyroid nodules was 36%. A low ROM was seen in thyroid nodules without suspicious ultrasonographic findings, independent of the FDG-PET/CT result.
NCT02150772 registered 14th of April 2014.
FDG-avid 甲状腺偶发瘤的恶性肿瘤风险(ROM)在不同的研究中有所不同,这可能是由于 FDG-PET/CT 上描绘的解剖定位与组织病理学检查之间的不一致所导致的。本研究旨在确保 FDG-PET/CT 确定的肿瘤与组织病理学检查之间的解剖一致性,从而评估 PET 阳性和 PET 阴性甲状腺结节的恶性肿瘤风险(ROM)。此外,还确定了术前提示甲状腺恶性肿瘤的特征。
前瞻性纳入 32 例接受甲状腺手术的患者。所有患者均行 FDG-PET/CT、细针穿刺活检和甲状腺超声检查。通过组织病理学检查确定指数结节的确切解剖定位,以确保与 FDG-PET/CT 结果一致。
共纳入 40 个甲状腺结节。28 个 PET 阳性结节中有 10 个为恶性,12 个 PET 阴性结节中有 1 个为恶性,ROM 分别为 36%和 8%。在良性结节和 PET 阳性扫描的患者中,50%发现 Hurthle 细胞瘤。1 个 PET 阴性结节为乳头状微癌。在 PET 阳性结节中,甲状腺超声的低回声、不规则边缘和病理性淋巴结是与恶性肿瘤相关的特征。
在这项研究中——确保 PET 结果与组织病理学检查之间的解剖一致性——PET 阳性甲状腺结节的恶性肿瘤风险为 36%。在没有可疑超声表现的甲状腺结节中,无论 FDG-PET/CT 结果如何,恶性肿瘤风险均较低。
NCT02150772,于 2014 年 4 月 14 日注册。